Orexo Financial Statements From 2010 to 2025
| ORXOF Stock | USD 1.08 0.00 0.00% |
Check Orexo AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orexo AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Orexo financial statements analysis is a perfect complement when working with Orexo AB Valuation or Volatility modules.
Orexo |
Orexo AB OTC Stock Return On Equity Analysis
Orexo AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Orexo AB Return On Equity | -0.65 |
Most of Orexo AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orexo AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Orexo AB has a Return On Equity of -0.6535. This is 97.27% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 110.81% higher than that of the company.
Orexo AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Orexo AB's current stock value. Our valuation model uses many indicators to compare Orexo AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orexo AB competition to find correlations between indicators driving Orexo AB's intrinsic value. More Info.Orexo AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orexo AB's earnings, one of the primary drivers of an investment's value.About Orexo AB Financial Statements
Orexo AB stakeholders use historical fundamental indicators, such as Orexo AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Orexo AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Orexo AB's assets and liabilities are reflected in the revenues and expenses on Orexo AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Orexo AB. Please read more on our technical analysis and fundamental analysis pages.
Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. Orexo Ab is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Orexo OTC Stock
Orexo AB financial ratios help investors to determine whether Orexo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Orexo with respect to the benefits of owning Orexo AB security.